Page 6«..5678..20..»

Category Archives: ALS Treatment

Locked-in syndrome and the misplaced presumption of misery – Ars Technica

Posted: Published on August 10th, 2022

In 1993, Julio Lopes was sipping a coffee at a bar when he had a stroke. He fell into a coma, and two months later, when he regained consciousness, his body was fully paralyzed Continue reading

Posted in ALS Treatment | Comments Off on Locked-in syndrome and the misplaced presumption of misery – Ars Technica

APELLIS PHARMACEUTICALS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) – Marketscreener.com

Posted: Published on August 10th, 2022

The following discussion and analysis of our financial condition and results ofoperations should be read in conjunction with our unaudited condensed financialstatements and related notes appearing elsewhere in this Quarterly Report onForm 10-Q and our audited financial statements and related notes for the yearended December 31, 2021 included in our Annual Report on Form 10-K filed withthe Securities and Exchange Commission on February 28, 2022, which we refer toas the 2021 Annual Report on Form 10-K.This Quarterly Report on Form 10-Q contains forward-looking statements thatinvolve substantial risks and uncertainties. Continue reading

Posted in ALS Treatment | Comments Off on APELLIS PHARMACEUTICALS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) – Marketscreener.com

Sen. Marshall Amendment Protects Access to Breakthrough Treatments and Life-Saving Medicine – Roger Marshall

Posted: Published on August 10th, 2022

(Washington, D.C., August 6, 2022) U.S. Senator Roger Marshall, M.D. will offer an amendment to the Democrats reckless, more than $700 billion reconciliation package in an effort to protect Americans current and future access to breakthrough treatments and life-saving medicine by excluding them from federal government-controlled drug pricing. Continue reading

Posted in ALS Treatment | Comments Off on Sen. Marshall Amendment Protects Access to Breakthrough Treatments and Life-Saving Medicine – Roger Marshall

Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA …

Posted: Published on June 26th, 2022

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx or the Company) today announced that Health Canada has approved ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine), with conditions, for the treatment of amyotrophic lateral sclerosis (ALS). Continue reading

Posted in ALS Treatment | Comments Off on Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA …

FDA Approves Oral Form of ALS Treatment

Posted: Published on June 26th, 2022

Action FDA has approved Radicava ORS (edaravone) oral suspension for the treatment of adults with amyotrophic lateral sclerosis (ALS). Radicava ORS is an orally administered version of Radicava, which was originally approved in 2017 as an intravenous (IV) infusion to treat ALS, commonly referred to as Lou Gehrigs disease Continue reading

Posted in ALS Treatment | Comments Off on FDA Approves Oral Form of ALS Treatment

ALS (Lou Gehrig’s Disease): Causes, Symptoms & Treatment

Posted: Published on June 26th, 2022

Amyotrophic lateral sclerosis (ALS) is a degenerative disease that affects the brain and spinal cord. ALS causes a loss of voluntary muscle control that worsens over time. This affects movements like talking, swallowing, and walking. Continue reading

Posted in ALS Treatment | Comments Off on ALS (Lou Gehrig’s Disease): Causes, Symptoms & Treatment

The best sleeping position to prevent Alzheimers, ALS and Parkinsons, according to new study – Seniors Matter

Posted: Published on June 26th, 2022

On your back, face down, on the sidewhen youre napping or going to bed for the night, what position do you tend to sleep in? A pre-clinical study suggests how we sleep, especially if its in a lateral position (also known as side-sleeping), can help flush out waste in the brain as we sleep. This waste removal is essential in carrying out brain functions like problem-solving, reasoning and attention to detailalong with keeping your brain healthy Continue reading

Posted in ALS Treatment | Comments Off on The best sleeping position to prevent Alzheimers, ALS and Parkinsons, according to new study – Seniors Matter

Hoping to build ALS awareness, this Cypress woman will take the pageant stage for the first time – Houston Chronicle

Posted: Published on June 26th, 2022

This is a carousel. Use Next and Previous buttons to navigate Lluvia Alzate is competing in the Miss Texas USA pageant to raise awareness for ALS, a neurological disease her mother was diagnosed with in 2019. Lluvia Alzate is competing in the Miss Texas USA pageant to raise awareness for ALS, a neurological disease her mother was diagnosed with in 2019 Continue reading

Posted in ALS Treatment | Comments Off on Hoping to build ALS awareness, this Cypress woman will take the pageant stage for the first time – Houston Chronicle

John Driskell Hopkins talks about living with ALS and finding ‘solutions’ for disease through his nonprofit – Yahoo News

Posted: Published on June 26th, 2022

John Driskell Hopkins is perfectly in tune. The 51-year-old multi-instrumental musician, who goes by the name "Hop," has played in front of millions of fans across the world as a founding member of the Grammy award-winning group Zac Brown Band Continue reading

Posted in ALS Treatment | Comments Off on John Driskell Hopkins talks about living with ALS and finding ‘solutions’ for disease through his nonprofit – Yahoo News

Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease – Business Wire

Posted: Published on June 26th, 2022

VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (Alpha Cognition, or the Company), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative disorders, today announced positive results from its pivotal bioequivalence study with ALPHA-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate Alzheimers Disease (AD) Continue reading

Posted in ALS Treatment | Comments Off on Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease – Business Wire

Page 6«..5678..20..»